Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	693	465	157	29	35	62
Market Cap Growth	20.19%	195.83%	434.24%	-16.81%	-42.59%	1.75%
Enterprise Value	678	468	159	27	31	61
Last Close Price	0.65	0.43	0.15	0.03	0.03	0.06
PE Ratio	-	-	7.81	8.26	3.97	12.10
PS Ratio	6.58	5.53	2.77	0.86	1.10	2.42
PB Ratio	14.54	8.68	2.73	1.01	1.40	3.81
P/TBV Ratio	14.63	8.73	2.74	1.03	1.43	3.92
P/FCF Ratio	38.48	79.70	-	-	5.88	21.50
P/OCF Ratio	36.33	62.33	-	8.81	5.43	19.27
EV/Sales Ratio	6.43	5.56	2.81	0.80	0.96	2.40
EV/EBITDA Ratio	16.41	20.43	13.09	5.25	4.94	17.86
EV/EBIT Ratio	17.38	22.05	14.75	6.92	6.11	28.90
EV/FCF Ratio	37.64	80.19	-	-	5.15	21.24
Debt / Equity Ratio	0.14	0.20	0.20	0.13	0.11	0.15
Debt / EBITDA Ratio	0.16	0.46	0.95	0.73	0.43	0.66
Debt / FCF Ratio	0.37	1.87	-	-	0.46	0.83
Asset Turnover	1.06	0.93	0.91	0.90	1.05	0.99
Inventory Turnover	2.81	3.01	2.69	2.16	2.97	2.95
Quick Ratio	5.39	3.42	2.04	1.40	1.73	1.15
Current Ratio	7.23	4.88	3.07	2.75	2.82	2.10
Return on Equity (ROE)	-20.42%	-7.77%	46.47%	13.15%	43.01%	37.96%
Return on Assets (ROA)	24.50%	14.72%	10.83%	6.52%	10.33%	5.14%
Return on Capital (ROIC)	39.27%	19.82%	13.20%	8.15%	13.62%	7.92%
Return on Capital Employed (ROCE)	38.80%	25.10%	15.30%	12.00%	17.80%	10.30%
Earnings Yield	-1.56%	-0.93%	12.80%	12.11%	25.18%	8.27%
FCF Yield	2.60%	1.26%	-2.57%	-8.15%	17.00%	4.65%
Buyback Yield / Dilution	-2.86%	-4.40%	-1.02%	-0.23%	-7.17%	5.06%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.